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        The mechanism resulting in increased numbers 
of microglia in the central nervous system 
(CNS) during infl  ammation has long been de-
bated. Microglia have been shown to prolifer-
ate in situ in several synthetic infl  ammatory 
models (  1  –  4  ). In contrast, it is suggested that 
microglia can diff  erentiate from blood-derived 
precursors that migrate into the CNS; how-
ever, recent reports suggest that this can only 
occur after radiation-induced   “  preconditioning  ”   
of the brain (  5  –  10  ). Whether viral infection 
initiates events resulting in microglial recruitment 
from the periphery is unknown. 
  During embryonic development, microglia 
populate the CNS from myeloid lineage precur-
sors in the BM (  11  ). Much is known about early 
monocyte lineage precursors, but the diff  erentia-
tion to downstream eff  ector populations in the 
adult remain poorly defi  ned. Geissman et al. (  13  ) 
have described two major subsets in the periph-
eral blood, the   “  infl  ammatory  ”   and   “  circulating  ”   
monocyte (  12, 14  ). Infl  ammatory monocytes ex-
press Ly6C  hi   (Gr1) and the chemokine receptor 
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  In a lethal West Nile virus (WNV) model, central nervous system infection triggered a 
threefold increase in CD45  int  /CD11b  +  /CD11c        microglia at days 6  –  7 postinfection (p.i.). Few 
microglia were proliferating, suggesting that the increased numbers were derived from a 
migratory precursor cell. Depletion of   “  circulating  ”   (Gr1       (Ly6C  lo  )CX3CR1  +  ) and   “  infl  amma-
tory  ”   (Gr1  hi  /Ly6C  hi  /CCR2  +  ) classical monocytes during infection abrogated the increase in 
microglia. C57BL/6 chimeras reconstituted with cFMS  –  enhanced green fl  uorescent protein 
(EGFP) bone marrow (BM) showed large numbers of peripherally derived (GFP  +  ) microglia 
expressing GR1  +  (Ly6C  +  ) at day 7 p.i., suggesting that the infl  ammatory monocyte is a 
microglial precursor. This was confi  rmed by adoptive transfer of labeled BM (Ly6C  hi  /CD115  +  ) 
or circulating infl  ammatory monocytes that traffi  cked to the WNV-infected brain and 
expressed a microglial phenotype. CCL2 is a chemokine that is highly expressed during WNV 
infection and important in infl  ammatory monocyte traffi  cking. Neutralization of CCL2 not 
only reduced the number of GFP  +   microglia in the brain during WNV infection but pro-
longed the life of infected animals. Therefore, CCL2-dependent infl  ammatory monocyte 
migration is critical for increases in microglia during WNV infection and may also play a 
pathogenic role during WNV encephalitis. 
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staining in this region of the brain (  Fig. 1, A and B  ).   Between 
days 3 and 7 p.i., the morphology of microglia changed. Early 
activated microglia displayed a dendritic morphology and 
stained intensely with GS-lectin (  Fig. 1 B  ). However, with pro-
gression of infection, as evident by the spread of NS-1 immuno-
reactivity throughout the brain (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20080421/DC1), microglia with 
enlarged cell bodies and retracted processes (stout morphology), 
as well as those with amoeboid morphology, including rod-
shaped and round phagocytic forms, became evident (  Fig. 1, C 
and D  ; Fig. S1). Rod-shaped microglia were found predomi-
nantly in clusters around neurons or near perivascular cuff  s and 
resembled previously described perivascular microglia, also 
known as Mato cells (  Fig. 1, E and F  ) (  36  ). 
  Microglia express many markers in common with macro-
phages. As such, many studies have failed to distinguish cor-
rectly between microglia and macrophages. In this study, we 
used the positive expression of CD11b in conjunction with 
the diff  erential expression of CD45 antigen on the cell sur-
face using fl  ow cytometry, as originally described by Sedgwick 
et al. (  30  ). In this way, resting microglia can be diff  erentiated 
from activated microglia, as well as from macrophages (  26  ). 
Ramifi  ed or resting microglia express a CD45  lo   phenotype, 
increasing their cell surface expression to an intermediate 
(int) level upon activation. Importantly, activated CD45  int   
microglia express a lower level of CD45 than macrophages in 
the CNS, enabling these two cell types to be diff  erentiated 
from each other (  30  ). 
  As expected, the expression of CD45 on leukocytes isolated 
either from mock-infected mouse brains or at day 0 p.i. was 
uniformly low (resting microglia [references   26, 30  ];   Fig. 1 G   
and not depicted). By day 7 p.i., brains infected with WNV dis-
played a heterogenous CD45 versus CD11b profi  le. Relatively 
few CD45  lo   microglia were present, whereas a CD45  int   (acti-
vated microglia) population was present and could be distin-
guished from a signifi   cant population of CD11b  +  /CD45  hi   
macrophages (  Fig. 1 H  ). The increase in CD45 expression on 
microglia is indicative of activation of these cells. Analysis of 
Ly6G and Ly6C expression on these resting and activated mi-
croglia (  Fig. 1, I and J  ) showed a signifi  cant increase in Ly6C ex-
pression on CD45  int   microglia. The absence of Ly6G expression 
confi  rms that these cells are not granulocytes. 
  Enumeration of microglia by fl  ow cytometry showed that 
WNV infection resulted in an increase in the absolute number 
of CD45  int   microglia (  Fig. 1, H and K  ). Overall microglial cell 
numbers (CD45  lo+int  ) were not statistically diff  erent until day 7 
p.i. By day 7 p.i., the total numbers of microglia increased by 
three- to fourfold (  Fig. 1 K  ). The diff  erential contributions 
of resting and activated microglia are also shown in   Fig. 1 K  . 
CD45  int   cells, virtually absent on day 0 p.i., were found in low 
numbers on day 3 p.i., correlating with the increase in lectin la-
beling by IHC. Numbers of CD45  int   microglia had increased 
signifi  cantly by day 7 p.i. In contrast, numbers of CD45  lo   mi-
croglia had signifi  cantly decreased at day 6 compared with day 3 
p.i. and were signifi  cantly lower than CD45  int   microglial num-
bers at day 7 p.i. Because numbers of total microglia at day 6 
CCR2 (  12  –  14  ). CCR2 and one of its ligands, CCL2, are evi-
dently important in both emigration of these monocytes from 
the BM and their immigration into infl  amed tissues (  15, 16  ). In-
fl  ammatory monocytes migrate to the spleen and skin, where 
they can diff  erentiate into macrophages and Langerhans cells, 
respectively (  6, 13, 17  ). Circulating monocytes, identifi  ed by 
their low expression of Ly6C in conjunction with CX  3  CR  1  , are 
thought to be important in replenishing tissue macrophages dur-
ing homeostatic conditions (  12  ). 
  In this study, we have used West Nile virus (WNV) to in-
vestigate the in vivo traffi   cking and diff  erentiation of mono-
cyte/microglia during lethal encephalitis. Although it is clear 
from previous work that several elements of the systemic im-
mune system work together during WNV infection to control 
viral growth and dissemination (  18  –  20  ), it is also apparent that 
infi  ltrating CD11b  +  /CD45  +   myeloid cells contribute to un-
derlying immunopathology observed during WNV encepha-
litis (  21, 22  ). Although activated microglia have been observed 
during WNV infection of the brain (  19, 23  ), the contribution 
of microglia to immunopathology is unknown. Microglia are 
immune-competent cells of the CNS, comprising up to 20% 
of the total rodent glial population (  24  ). Resting microglia 
usually exhibit a ramifi  ed dendritic morphology and express 
low levels of cell surface immune molecules. However, altera-
tions in the microenvironment can result in rapid activation. 
Activated microglia acquire an amoeboid morphology 
(  25  –  28  ), develop an increase in phagocytic ability, exhibit en-
hanced migratory capacity within the brain, and increase their 
expression of cell surface glycoproteins including CD45 and 
MHC-II (  26, 29  –  34  ). 
  In this paper, we show for the fi  rst time in nonirradiated 
mice that Ly6C  hi   infl  ammatory monocytes migrate in a CCL2-
dependent fashion into the WNV-infected CNS, where they 
develop a microglial phenotype. Inhibition of microglial im-
migration seen after CCL2 neutralization correlated with 
enhanced survival of WNV-infected mice. Paradoxically, the 
titer of WNV in the CCL2-neutralized brains was similar 
to that observed in nontreated mice, indicating that patho-
genesis is not directly related to viral load and implicating 
CCL2-mediated microglial migration in the pathogenesis of 
WNV encephalitis. 
    RESULTS   
  Microglia become activated and increase in number 
in response to WNV infection 
  Sections of brains from C57BL/6 mice infected intranasally 
with WNV were labeled with GS-lectin and WNV NS-1 anti-
body to determine the extent of microglial activation and cellu-
lar infection. In normal brains, resting microglia exhibit a 
ramifi  ed morphology and express few     -  d  -galactose residues on 
their cell surface, making them diffi   cult to detect by immuno-
histochemistry (IHC) with GS-lectin (  35  ). However, upon ac-
tivation, expression of     -  d  -galactose on microglia increases and 
can be readily detected by IHC. Microglia showed prominent 
lectin staining in the outer layers of the olfactory bulb on day 3 
postinfection (p.i.), corresponding to the appearance of NS-1 JEM VOL. 205, September 29, 2008 
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  Microglia do not proliferate signifi  cantly in situ 
after WNV infection 
  As mentioned, several stimuli may induce microglial prolif-
eration, which is measurable by nuclear BrdU incorporation 
(  1  –  4, 9, 33, 34, 37, 38  ). However, in some of these studies, 
mice were exposed to BrdU for several days. This makes it 
p.i. were not signifi  cantly diff  erent from those of the earlier time 
points, this suggests that resting microglia are increasing their 
CD45 expression (as previously described); however, the signifi  -
cant increase in overall microglial numbers in the brain by day 7 
in WNV infection argues that there is either in situ microglial 
proliferation or external recruitment. 
    Figure 1.         Kinetics of microglial change during WNV infection.   WNV NS-1 protein fi  rst appeared in the outermost layer of the olfactory bulb on 
day 3 p.i. (A, arrowheads). Early activated microglia, identifi  ed by lectin staining and dendritic morphology, were concurrently detected in the outermost 
layer on day 3 p.i. (B, arrowheads and enlarged inset of the arrowed box) but nowhere else in the brain. On days 6 and 7 p.i. (C and D), scattered activated 
microglia (arrows and enlarged inset of the arrowed box) exhibited both amoeboid and intermediate activated morphology in the olfactory bulb. In the 
brain parenchyma, lectin-positive cells with amoeboid morphology (arrows and enlarged insets of arrowed boxes) were observed surrounding the blood 
vessels on days 6 (E) and 7 (F) p.i. Bars, 100   μ  M. Flow cytometry of leukocytes isolated from the whole brain in mock infected (G) showed a predominant 
population of resting microglia with a classical CD45  lo   phenotype (R1). By day 7 p.i., signifi  cant numbers of activated microglia could be identifi  ed by their 
CD45  int   expression, as indicated by R2 (H). Analysis of the total microglial population for Ly6G (I) and Ly6C (J) expression showed increased Ly6C ex-
pression on activated microglia but no Ly6G expression on resting or activated microglia. Enumeration of total microglia at days 0, 3, 5, 6, and 7 p.i. 
showed a major increase between days 6 and 7 p.i. (K). Increased numbers of CD45  int   (activated) microglia could be detected as early as day 3 p.i. (K), with 
numbers increasing dramatically between days 5 and 7. These changes were temporally independent of decreases in CD45  lo   (resting) microglial numbers, 
which declined from day 3 p.i. onwards. Data shown are means   ±   SD and are representative of three experiments with at least three mice per group. ***, 
P   <   0.001, comparing day-7 p.i. CD45  lo   with day-7 p.i. CD45  int ;   ###  , P   <   0.001, comparing day-7 p.i. total microglia with days 0, 5, or 6 p.i. using one-way 
analysis of variance (ANOVA) with a Tukey-Kramer posttest.     2322 LY6C  HI   MONOCYTES BECOME MICROGLIA IN ENCEPHALITIS   | Getts et al. 
blood to sites of infection in organs other than the brain and 
their diff  erentiation into eff  ector cells has been shown to in-
volve Ly6C  +   or Gr1  hi   monocytes (  13, 14, 46  ). Interestingly, 
31.3   ±   7% of activated microglia expressed Ly6C in WNV-
infected mice, compared with 12   ±   0.8% in mock-infected 
control mice (P   <   0.001). Furthermore, 7.6   ±   1.5% of resting 
microglia expressed detectable Ly6C in infected mice, com-
pared with 0.32   ±   0.2% in mock-infected control mice (P   <   
0.001). To determine whether blood-derived monocytes are 
microglial precursors during WNV infection, we depleted 
blood monocytes with clodronate-loaded (C-L) liposomes. It 
has previously been shown that liposomes do not deplete mac-
rophages in the brain parenchyma (  47, 48  ). Although perivas-
cular cuff  s were evidently resistant to C-L liposome depletion 
in WNV-infected mice (  Fig. 3, A  –  L  ), we additionally used Dil-
labeled (D-L) liposomes to further confi  rm visually that lipo-
somes do not have access to the CNS during WNV infection 
(  Fig. 3, M  –  X   and top right insets).   After injection, D-L lipo-
somes were abundantly localized to the splenic marginal zones 
in both infected and mock-infected mice (  Fig. 3, M  –  T  ). In 
contrast, no D-L liposomes were found in the brains of either 
day-7 WNV-infected mice (  Fig. 3, U  –  X  ) or mock-infected 
mice (  Fig. 3 X  , bottom left inset), confi  rming that liposomes do 
not cross the BBB. This further supports the data in the previ-
ous section, indicating that little or no BBB breakdown occurs 
in this model. Overall, these data support previously published 
reports and indicate that this method of depletion primarily af-
fects peripheral monocyte populations, especially the infl  am-
matory monocyte compartment (Fig. S4, available at http://www
.jem.org/cgi/content/full/jem.20080421/DC1) (  49  ). 
  Clodronate liposome treatment of WNV-infected mice 
1 d before infection and then every other day onwards re-
sulted in signifi  cantly reduced numbers of microglia in the 
brain, as detected using fl  ow cytometry, on day 7 p.i., com-
pared with WNV-infected mice without treatment or treated 
with nondepleting null liposomes (  Fig. 3 Y  ). As C-L lipo-
somes do not delete any myeloid cells behind the BBB but 
cause a signifi  cant reduction in the number of microglia in 
the brain, this strongly suggests that the increased numbers 
of microglia in the brain in WNV encephalitis are derived 
from blood monocytes. 
  Increased microglial numbers in WNV infection are derived 
from the blood 
  To further investigate possible microglial precursors during 
WNV infection, we used the cFMS-EGFP mouse. cFMS 
is the colony stimulating factor receptor 1, CD115, and is 
largely restricted to cells of the macrophage lineage (  50  ). 
Microglia in the normal brain are mostly quiescent and 
thus radio resistant. Therefore, chimeric mice were made, in 
which BM from C57BL/6-7.2fms-EGFP transgenic (CD45.2) 
mice was used to reconstitute    -irradiated C57BL/6 congenic 
B6.SJL-Ptprc  a  Pep3  b  /BoyJ (CD45.1) mice (Fig. S5, A –  C, avail-
able at http://www.jem.org/cgi/content/full/jem.20080421/
DC1). This chimera allowed us to diff  erentiate  between 
resident (GFP       ) and infi  ltrating (GFP  +  ) microglia (  50  ). 
impossible to exclude the possibility that BrdU  +   microglia in 
these models arose from precursor cells that had proliferated 
in peripheral sites, such as the BM, and subsequently migrated 
to the brain. Therefore, groups of WNV-infected mice were 
pulsed i.v. with BrdU for 3 h on either day 6 or 7 p.i., when 
maximal increases in microglia were occurring, and killed 
immediately after the pulse period. 
  In WNV-infected mice on either day 6 or 7 p.i., the fre-
quency of BrdU  +   cells was low. Of the total BrdU  +   cells 
counted in brain sections from infected mice,   >  70% were lo-
calized within perivascular cuff  s on both days 6 and 7 p.i., with 
very few observed in the brain parenchyma (  Fig. 2, A, B, and D  ).   
Labeling in day-7 p.i. WNV-infected mice not treated with 
BrdU (  Fig. 2 C  ) or in BrdU-treated mock-infected mice (not 
depicted) showed virtually no positively labeled cells in any ar-
eas of the brain (  Fig. 2 D  ). This was further supported by fl  ow-
cytometric analysis, which showed that     1% of microglia in 
WNV infection were BrdU  +   at day 7 p.i. (  Fig. 2, E and F  ; and 
Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20080421/DC1). The combination of the very low fre-
quency of BrdU  +   microglia in WNV-infected mice, their pre-
dominantly perivascular location during the period of greatest 
increase in activated microglia, and the relatively small reduc-
tion in absolute numbers of resting microglia (  Fig. 1 K  ) makes 
it unlikely that in situ proliferation can account for the large 
numbers of activated microglia seen at day 7 p.i. 
  Microglial increases are not caused by breakdown 
of the blood-brain barrier (BBB) 
  Breakdown of the BBB may explain the signifi  cant burst 
in numbers of microglia seen in the WNV-infected mouse 
brain between days 6 and 7 p.i. We investigated the status of 
the BBB by fi  brinogen IHC in the WNV-infected brain at 
the peak of disease (day 7 p.i.). The presence of fi  brinogen has 
previously been described to detect microvascular leakage in 
the brain during several distinct neuroinfl  ammatory models 
and on postmortem brain tissue (  39  –  44  ). Although all mice 
infected with WNV had severe leukocyte infi  ltration and 
perivascular cuffi   ng, 70% of infected mice (7/10) displayed 
no detectable fi  brinogen immunoreactivity (  Fig. 2, J  –  L  ), 
whereas fi  brinogen staining in the remaining mice was ex-
tremely scant and limited to the luminal side of the endothe-
lium (  Fig. 2, M  –  R  ). In addition, administration of Evans blue, 
1 h before sacrifi  ce on day 7 p.i., showed that BBB breakdown 
was similarly sporadic, with two out of six mice showing 
some Evans blue leakage into the brain (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20080421/DC1). 
Therefore, similar to other routes of WNV infection (  45  ), 
the intranasal route of WNV infection causes sporadic 
BBB breakdown. 
  Microglial numbers are reduced in monocyte-depleted 
WNV-infected mice 
  Microglial infi  ltration into the brain has been suggested to oc-
cur in several models; however, this has not been addressed 
during viral encephalitis. Recruitment from the peripheral JEM VOL. 205, September 29, 2008 
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    Figure 2.         There is little cellular proliferation and negligible BBB disruption during WNV encephalitis.   Mice were treated with BrdU for 3 h be-
fore sacrifi  ce. Routine IHC for BrdU showed that BrdU  +   cells localized predominantly to the perivascular cuff on days 6 (A) and 7 (B) p.i. This was not seen 
in mock-infected mice or mock BrdU-treated WNV-infected mice (C). Enumeration of BrdU  +   cells on histological sections showed that   >  70% of all BrdU  +  
cells were perivascularly localized (D). The percentage of proliferating microglia was also determined by fl  ow cytometry (E and F). Approximately 1% of 
microglia in WNV-infected and mock-infected mice were seen to be BrdU  +   (E and F). To test the status of the BBB, fi  brinogen IHC was performed on 10 
WNV-infected mice and 5 mock-infected mice. Fibrinogen was not detected in any mock-infected mice at day 7 p.i. (0/5; G  –  I). Furthermore, 7/10 WNV-
infected mice also failed to exhibit any evidence of fi  brinogen leakage (J  –  L). In the three mice where fi  brinogen labeling was detected, staining was scant 
and limited to the luminal surface of vessels (M  –  O, 20  ×  ; P  –  R, 100  ×   images of M  –  O). Data shown are means   ±   SD. Data from BrdU experiments are repre-
sentative of two experiments with at least fi   ve  mice  per  group.  Bars:  (A – C)  100   μ M;  (G – O)  200   μ M;  (P – R)  50   μ M.   2324 LY6C  HI   MONOCYTES BECOME MICROGLIA IN ENCEPHALITIS   | Getts et al. 
    Figure 3.         C-L liposomes do not enter the WNV-infected CNS.   Liposomes loaded with clodronate were injected i.v. at day 7 p.i. and, 6 h later, mice 
were killed. Hematoxylin and eosin (H  &  E) staining of brain sections showed no perivascular cuffi  ng in mock-infected animals (A and B). In contrast, 
distinct perivascular cuffs were observed in the WNV-infected C-L liposome  –  treated group (E and F) and the WNV-infected PBS liposome-treated group 
(I and J). To confi  rm that the cells within these cuffs were of myeloid lineage, we stained sections, consecutive to those stained with H  &  E, with lectin. 
Lectin staining in brain sections from mock-infected mice confi  rmed the absence of perivascular cuffi  ng (C and D). In contrast, most of the cells within JEM VOL. 205, September 29, 2008 
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cause there was negligible breakdown of the BBB in this viral 
model, we further investigated the ability of infl  ammatory 
monocytes to penetrate the CNS using tracking techniques 
in nonirradiated mice. 
  First, we tested the ability of infl  ammatory monocytes 
(Ly6C  hi  /CD11b  +  /cFMS-EGFP  +    {  CD115  +    }  ) and circulating 
monocytes (Ly6C  lo  /CD11b  +  /cFMS-EGFP  +    {  CD115  +    }  ) to 
traffi   c to the CNS. To do this, we adoptively transferred 
10  6   EGFP  +  /CMTMR  –  cell tracker orange  +   BM-derived in-
fl  ammatory monocytes (Ly6C  hi  ) together with 10  6   EGFP  +  /
CMTMR  –  cell tracker orange        BM-derived circulating mono-
cytes (Ly6C  lo  ) at day 6.5 p.i. (  Fig. 5, A  –  D  ).   12 h later, the 
presence of these cells in the brain was investigated using fl  ow 
cytometry (  Fig. 5, E  –  I  ). Although recovery of adoptively 
transferred cells was low, the number of EGFP  +   cells in the 
brain was signifi  cantly greater in the WNV-infected animal 
(  Fig. 5 F  , 0.03%) than in the mock-infected mouse (  Fig. 5 G  , 
0.005%). Cell tracker orange  +   GFP  +   Ly6C  hi   cells comprised 
  >  90% of adoptively transferred cells isolated from the brain 
(  Fig. 5 I  ). Interestingly, both CD45  int  - and CD45  hi  -expressing 
GFP  +   cells were isolated from the WNV-infected brain (  Fig. 
5 H  ), suggesting that Ly6C  hi   precursors may diff  erentiate into 
either microglia or macrophages. This was also seen when we 
transferred GFP  +   Ly6C  hi   and GFP  +   Ly6C  lo   monocytes sepa-
rately into mock-infected mice (  Fig. 5, J and L  –  N  ) or WNV-
infected mice at day 6 p.i. (  Fig. 5, K and O  –  Q  ). 
  As a second test to confi  rm the role of infl  ammatory mon-
ocytes as microglial precursors during WNV encephalitis, we 
used an in vivo bead labeling system that was previously de-
scribed (  51, 52  ). Using clodronate liposome depletion at day 
5.5 p.i. with FITC polystyrene bead injection 12 h later, we 
were able to recapitulate the stable labeling of circulating 
Ly6C  hi   infl  ammatory monocytes in WNV-infected mice (  Fig. 
6, A  –  F  ), as was previously described in uninfected mice (  14, 
51  ).   In brief, injection of FITC beads alone into WNV-
infected mice at day 6 p.i. resulted in the stable labeling of 
GR1  lo   monocytes in the circulation (  Fig. 6, B and D  ). In con-
trast, prior C-L liposome  –  mediated depletion before bead in-
fusion resulted in stable labeling of GR1  hi   or infl  ammatory 
monocytes (  Fig. 6, C and E  ). 
  Flow cytometric examination of the WNV-infected brain 
at day 7 p.i. in mice where infl  ammatory monocytes were la-
beled with beads after C-L liposome treatment revealed a strong 
bead  +  /CD45  int  /CD11b  +  /CD11c        population of microglia 
(  Fig. 6 J  ), which was absent in non  –  bead-treated (  Fig. 6 H  ) 
  Histological examination revealed that both GFP  +   peri-
vascular macrophages (  Fig. 4 A  , white arrow) and GFP  +   pa-
renchymal ramifi  ed microglia (  Fig. 4 B  ) accounted for a small 
percentage of cells in the mock-infected brain, which is con-
sistent with previous work (  Fig. 4, G and H  ) (  7  ).   Similar to 
C57BL/6 mice, WNV-infected chimeric mice developed 
encephalitis and were moribund by day 7 p.i. (unpublished 
data). WNV-infected cFMS-EGFP chimeras displayed numer-
ous GFP  +   cells in all regions of the brain by day 7 p.i. (  Fig. 4, 
C and D  ). Of particular note, the distribution of these GFP  +   
cells was mostly within perivascular cuff  s (  Fig. 4 C   and inset). 
In addition, cells nearest the center of the perivascular cuff   
appeared to have a round monocytic morphology (  Fig. 4 C  , in-
set, white arrow), whereas those nearer to the brain paren-
chyma on the periphery of the perivascular cuff  s were more 
rod shaped (inset, red arrow), suggesting monocyte diff  eren-
tiation as cells enter the parenchyma. 
  Flow cytometric analysis at day 7 p.i. confi  rmed that at 
least 50 –  75% of activated microglia (CD45  int  /CD11b  +  /CD11c       ) 
expressed GFP, indicating that they were peripherally de-
rived (  Fig. 4, E and G  ). Furthermore, at this time point, 
75% of these activated GFP  +   microglia also expressed the in-
fl  ammatory monocyte-associated Gr1 (Ly6C;   Fig. 4, F and I  ). 
In contrast, most resting microglia (CD45  lo  /CD11b  +  /CD11c       ) 
from both mock-infected and WNV-infected chimeras were 
GFP       , indicating that they were of resident origin (mock 
infected, 93   ±   3.0%; WNV-infected, 88   ±   3.9%;   Fig. 4 H  ). 
Adding together the data in   Fig. 4 (G and H  , right), it can 
be seen that the total number of GFP        microglia (i.e., acti-
vated and resting) in WNV-infected mice was not signifi  -
cantly diff  erent from the total number of GFP        microglia 
in mock-infected mice. This suggests that proliferation of 
microglia in situ in the brain is unlikely to be the major 
mechanism for increased microglial numbers during WNV 
encephalitis. Furthermore, the proportion of GFP  +   CD45  int   
microglia expressing GR1 in the WNV-infected mouse 
supports the diff  erentiation of these microglia from a blood-
derived precursor, specifi  cally the GR1-expressing infl  am-
matory monocyte. 
  Adoptively transferred Ly6c  hi  , not Ly6C  lo  , cells traffi  c 
to the CNS within 12 h of transfer 
  It has previously been reported that the ability of infl  ammatory 
monocytes to penetrate the CNS in chimeric mice is caused 
by irradiation preconditioning of the CNS. Therefore, be-
the perivascular cuff were lectin  +   in both the WNV-infected C-L liposome  –  treated (G and H) and the PBS liposome-treated (K and L) groups. To further 
ensure that C-L liposomes used to deplete circulating monocytes did not enter the brain, we injected D-L liposomes at day 7 p.i. Dil was found in the 
marginal zones of mock- (M  –  P) and WNV (Q  –  T) -infected mouse spleens. However, no D-L liposomes were found in the WNV-infected brain (U  –  X) or 
the mock-infected brain (X, bottom left inset). Top right insets are higher power views of cells in representative fi  elds. Depletion of monocytes from the 
blood compartment with C-L liposomes from 1 d before infection and then every other day onwards resulted in a signifi  cant reduction in the numbers 
of microglia in WNV-infected mice compared with WNV-infected mice treated with null liposomes or mock-treated, as detected by fl  ow cytometry (Y). 
Data shown are from at least three mice per group and are representative. C-L liposome depletion data are means   ±   SD and are representative of three 
experiments with at least three mice per group. *, P   <   0.05 using a two-tailed T test. Bars: (A, C, E, G, I, K, and M  –  X) 200   μ  M; (B, D, F, H, J, L, and insets) 
50   μ M.   
 2326 LY6C  HI   MONOCYTES BECOME MICROGLIA IN ENCEPHALITIS   | Getts et al. 
cytes in the circulation (  Fig. 6, I  –  K  ). The pattern of GR1 
expression on bead  +   microglia was decreased, compared with 
circulating bead  +   infl  ammatory monocytes, suggesting that 
Ly6C is down-regulated when monocytes enter the infl  amed 
CNS (  Fig. 6 K  ). Levels of both MHC-II and CD86, in con-
trast, were higher on bead  +   microglia compared with bead        or 
bead  +   circulating infl  ammatory monocytes (  Fig. 6, L and M  ). 
  These adoptive transfer and bead-tracking experiments dem-
onstrate the traffi   c of infl  ammatory monocytes in nonirradiated 
and bead-only  –  treated WNV-infected controls (  Fig. 6 I  ). This 
data clearly suggests that the migration of bead  +   blood mon-
ocytes into the brain and subsequent diff  erentiation into mi-
croglia is a very rapid event. As this has not been described, 
and to ensure that these CD45  int  /CD11b  +   bead  +   cells isolated 
from the brain were not just recently migrated nondiff  erenti-
ated blood monocytes, we compared the expression of GR1, 
MHC-II, and the costimulation molecule CD86 on bead  +   CD-
45  int  CD11b  +   brain microglia and bead  +   infl  ammatory mono-
    Figure 4.         Histology and fl  ow cytometry of WNV-infected cFMS-EGFP chimeras.   Reconstitution of     -irradiated C57BL/6 congenic B6.SJL-Ptpr-
c  a Pep3 b  /BoyJ (CD45.1) mice with cFMS-EGFP BM resulted in chimeras in which a small number of GFP  +   cells were present in the CNS of mock-infected 
mice. Histologically, GFP  +   cells (white arrowheads) were usually seen around the perivascular space (A); however, a small number of ramifi  ed microglia 
expressing GFP were seen in the parenchyma (B). During WNV infection, a large infl  ux of GFP  +   cells was seen, in most cases located to the perivascular 
cuff (C, 20  ×   magnifi  cation). Insets (100  ×   magnifi  cation of the same fi  eld) show recruited round GFP  +   cells near the vessel lumen (white arrowhead) and 
rod-shaped GFP  +   cells closer to the parenchyma (red arrowhead). Gr1 (D, red) staining of chimeras clearly showed several Gr1  + /cFMS +   cells in the brain 
(D, yellow). Using fl  ow cytometry (E), it was clear that a large proportion of GFP  +   cells were CD45  int   microglia (R2) and CD45  hi   macrophages (blue dots), as 
well as Gr1  +   (F). Signifi  cantly more (approximately fourfold) CD45  int   microglia were GFP  +   at day 7 p.i., compared with mock-infected mice (G), whereas 
there were signifi  cantly fewer GFP        CD45 lo   resting microglia at day 7 p.i., compared with mock-infected mice (H). Signifi  cantly more (at least fourfold) 
GFP  +   CD45 int   microglia were Gr1  +   at day 7 p.i., compared with mock-infected mice (I). Gr1 data shown are means   ±   SD and are representative of four 
experiments with at least three mice per group (***, P   <   0.001, two-tailed unpaired   t   test). Bars: (A and D) 200   μ  M; (B and C) 100   μ  M; (insets) 50   μ  M.     JEM VOL. 205, September 29, 2008 
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    Figure 5.         Adoptively transferred Ly6C  hi   monocytes traffi  c into the WNV-infected CNS.   Ly6C hi /CD11b + /GFP +   and  Ly6C lo /CD11b + /GFP +   BM  cells 
were sorted as shown (A  –  C) from day 6 WNV-infected cFMS-EGFP transgenic mice. Ly6C  hi   monocytes were labeled as described in Materials and methods 
with CTMR  –  cell tracker orange (D). A 1:1 ratio of Ly6C  hi /Ly6C lo   cells was intravenously injected into WNV-infected mice on day 6.5 p.i. or into mock-in-
fected mice, whereas some mice received no cells. Leukocytes were isolated from the brains of these WNV-infected mice receiving no cells (E) and from 
WNV-infected (F) and mock-infected (G) brains 12 h after transfer. GFP  +   cells were only found in the CNS of WNV-infected mice (F), with the adoptively 
transferred cells expressing differential levels of CD45 (H) as indicated by markers M1 (CD45  int  ) and M2 (CD45  hi  ). More Ly6C  hi   (GFP +  /CTMR cell tracker 
orange  +  ) BM cells were found to track to the WNV-infected brain than Ly6C  lo   (GFP + /CTMR – cell  tracker  orange      ) BM cells (I). This was also observed when 
we injected these populations of cells separately into mock-infected (J and L  –  N) or WNV-infected mice (K and O  –  Q). Data are representative of two ex-
periments with at least four mice per group. Bars, 50   μ  M.     2328 LY6C  HI   MONOCYTES BECOME MICROGLIA IN ENCEPHALITIS   | Getts et al. 
    Figure 6.         Bead-labeled infl  ammatory monocytes, not GR1  lo   monocytes, traffi  c into the WNV-infected brain.   As a second method for traffi  ck-
ing monocytes, we stably labeled peripheral Ly6C  hi   monocytes, as previously described (  14, 51  ) (A  –  F). WNV-infected mice receiving no FITC beads had no 
circulating bead  +   cells (A). WNV-infected mice that received only beads with no prior macrophage depletion with C-L liposomes only had beads inside 
Ly6C  lo   monocytes (R2  B  ; B and D). In contrast, C-L liposome depletion in WNV-infected mice before bead injection resulted in the labeling of Ly6C  hi   infl  am-
matory monocytes (R2  C+B  ; C, E). The successful labeling of Ly6C  hi   versus  Ly6C lo   is  confi  rmed by overlaying R2  B   and  R2 C+B   (F). Finally, when we looked for 
the presence of beads in microglia (gated as shown in G) in WNV-infected mice, we found none in the non  –  bead-treated group (H) or the group in which 
Ly6C  lo   peripheral monocytes were labeled with beads (I). However, in WNV-infected mice where we labeled the Ly6C  hi   monocyte population with beads JEM VOL. 205, September 29, 2008 
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the GR1  hi   cell numbers in the blood but had little eff  ect on 
the GR1  lo   monocyte numbers (  Fig. 8 D  , left). Thus, Gr1  hi   
cells are evidently inhibited from immigrating into the brain in 
CCL2-neutralized WNV-infected mice, both at the level of 
the BBB and during egress from the BM. In contrast, over this 
short period of time (12 h), no changes were observed in blood 
and BM monocyte compartments after CCL2 neutralization 
of mock-infected mice (Fig. S6, available at http://www
.jem.org/cgi/content/full/jem.20080421/DC1). This data 
indicates the importance of CCL2 in the traffi   cking of microglia 
from the BM to the brain during WNV encephalitis. 
  CCL2 neutralization prolongs survival 
  In initial CCL2 neutralization experiments, neutralized mice 
displayed reduced disease-induced behaviors, including sei-
zures, piloerection, and hunching (unpublished data). Treat-
ment of infected mice with neutralizing antibody over several 
days resulted in signifi  cantly prolonged survival time, compared 
with infected mice receiving either isotype antibody or PBS 
alone (  Fig. 8 E  ). Importantly, CCL2 neutralization had no ef-
fect on the titer of WNV in these mice, despite their increased 
survival (  Fig. 8 F  ). This indicates that the immigrating Ly6C  hi   
microglia arising from the BM are pathogenic in WNV en-
cephalitis. Importantly, these data also discount a role for these 
cells in dissemination of WNV to the brain in this model. 
    DISCUSSION   
  The role of monocyte traffi   cking as a mechanism for microg-
lial cell replenishment has been debated for some time. This 
has been fueled by the inability to identify microglia from 
other macrophage populations found in diseased brains. Us-
ing several methods, we have highlighted a critical role for 
peripheral Ly6C  hi   infl  ammatory monocytes and the chemo-
kine receptor ligand CCL2 in the ontogeny of microglia dur-
ing fatal WNV infection of the brain. 
  Although it is often argued that microglial proliferation is the 
mechanism behind increased microglial cell numbers seen during 
CNS infl  ammation, the low level of proliferation observed during 
WNV infection in conjunction with the ability of peripheral de-
pletion of both classical and circulating monocytes to signifi  cantly 
reduce the numbers of microglial cells in WNV-infected brains at 
day 7 p.i. suggest that the recruitment of a peripheral microglial 
precursor plays an important role in WNV encephalitis. 
  The peripheral blood contains two monocyte subsets, the 
infl  ammatory and circulating monocytes (  6, 13, 14, 17, 46, 49, 
51  ). Infl  ammatory monocytes are distinguished from circulating 
monocytes by their diff  erential expression of the Ly6C portion 
of the Gr1 complex (  6, 13, 17, 49  ). The similar expression of 
Ly6C on several CD45  int   microglia isolated from the WNV-
infected brain implicates infl  ammatory monocytes as a microg-
lial precursor pool (  13, 14, 49  ). 
mice and show clearly that the large burst of microglial num-
bers seen in the WNV-infected brain is caused by the recruit-
ment of infl  ammatory monocytes and is not the result of 
radiation-induced changes in the CNS. Furthermore, these 
data show that infl  ammatory monocyte diff  erentiation into 
microglia may occur in a shorter time frame than originally 
considered (  12, 34  ). 
  WNV infection triggers CCL2 production, which attracts 
infl  ammatory monocyte, microglial precursors 
  CCL2 has been implicated in the egress of monocytes from 
BM (  15, 16  ). We hypothesized that CCL2 may be involved in 
this process during WNV infection. Intranasal WNV infection 
of the CNS triggered the secretion of substantial amounts of 
CCL2 protein in the brain, beginning on day 5 and increasing 
until the time of death (  Fig. 7 A  ).   The kinetics of these high 
brain levels were mirrored by much lower levels in the serum 
(  Fig. 7 A  ). Message for this chemokine is shown in   Fig. 7 B   (i) 
near perivascular cuff  s by CCL2 mRNA in situ hybridization 
in the brain. Labeling for CCL2 protein in WNV-infected 
brains confi  rmed the presence of CCL2 protein at the perivas-
cular cuff  . However, costaining for viral antigen (NS-1), lectin, 
and CCL2 protein showed that many, though not all, virus-
infected neurons and some uninfected neurons were CCL2  +  , 
whereas only occasional microglia were CCL2  +  , suggesting that 
viral-infected neurons are a major source of CCL2 during 
WNV infection (  Fig. 7 B  , ii  –  v). 
  The data in the previous paragraph suggest that the CNS was 
the source of the serum CCL2 and that this induced the egress 
and observed migration of BM monocytes to the CNS. To test 
this, we injected CCL2-neutralizing antibody to inhibit both 
BM egress and CNS traffi   cking in cFMS-EGFP chimeras.   Fig. 
7 C   shows a statistically signifi  cant reduction in the number of 
GFP  +  /CD11b  +  /CD45  int   (reduced to 31%) and CD45  lo   (reduced 
to 29%) immigrating microglia isolated from the CNS on day 7 
p.i. after CCL2 neutralization, compared with isotype antibody-
treated WNV-infected mice. This indicates that a major factor in 
the immigration of microglia is CCL2. This was not attributable 
to irradiation because nonirradiated WNV-infected mice (  Fig. 7, 
D  –  G  ) also showed a reduction of up to 50% of total microglial 
numbers (  Fig. 7 G  ). This reduction was mostly accounted for by 
the reduction of Ly6C  hi   microglia to     20% of the levels seen in 
control isotype antibody-treated mice (  Fig. 7 G  ). 
  This was further refl  ected in chimeric mice by the analysis 
of GFP  +  /CD11b  +   monocytes in the blood and BM, using 
the gating strategy illustrated (  Fig. 8, A  –  C  ).   As expected, in the 
BM, signifi  cantly more Gr1  hi   cells were retained in the CCL2-
neutralized compared with the isotype antibody  –  treated mice, 
whereas Gr1  lo   cells were not statistically diff  erent between 
these groups (  Fig. 8 D  , right), confi  rming previous studies 
(  15  ). However, CCL2 neutralization signifi  cantly increased 
after C-L depletion, we found microglia-containing FITC beads (J). Furthermore, bead  +   microglia showed down-regulated GR1, compared with bead  +   in-
fl  ammatory monocytes (K), suggesting down-regulation upon entry in to the CNS. Finally, these bead-labeled monocyte-derived microglia had also 
up-regulated their expression of MHC-II (L) and CD86 (M) upon entry into the brain.     
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donor BM in conjunction with IHC directed against anti-
gens such as CD11b and IBA-1 (  5, 8  ). As these antigens are 
expressed equally in macrophages and microglia, defi  nitive 
identifi  cation of microglia and distinction from macrophages 
  BM chimeras have been successfully used to monitor mi-
croglial behavior in several disease models and allow for the 
diff  erentiation of resident and immigrant microglia (  5, 7, 8  ). 
However, these studies relied on the expression of     -actin in 
    Figure 7.         CCL2 protein kinetics and neutralization during WNV infection.   Using a multiplexed cytokine bead array, we measured both the serum 
and brain levels of CCL2. The level of CCL2 protein increased throughout infection in both brain and serum (A). CCL2 mRNA in the brain of fi  ve WNV-
infected mice on day 7 p.i. was often localized to perivascular cuffs (B, i, black arrowheads). Fluorescent antibody labeling for CCL2 protein (red) and NS-1 
(blue) showed that most cells expressing CCL2 were infected neurons (B, ii  –  iv; ii, white arrowheads). Not all infected neurons expressed CCL2 (B, ii and iii, 
white outlined arrowheads) and some uninfected neurons expressed CCL2. (B, v, white outlined arrowheads). The addition of lectin staining (green; B, 
iii  –  iv) showed that occasional perivascular microglia also expressed CCL2 faintly (B, iv, white arrowhead), whereas most microglia evidently did not 
(B, iii and v, white arrowheads). CCL2 in WNV-infected EGFP-cFMS chimeras was neutralized with intraperitoneal CCL2-neutralizing monoclonal antibody, 
resulting in a signifi  cant reduction in immigrant (GFP  +  ) microglia at day 7 p.i. (C). We also determined whether this was also observed in nonirradiated 
mice (D  –  G). In nonirradiated WNV-infected mice, CCL2 neutralization (F) resulted in signifi  cantly reduced numbers of microglia, accounted for by drastic 
reduction in Ly6C  hi  -expressing cells (G), which was not observed in mock- (D) and WNV (E) -infected mice. Data shown are means   ±   SD and are represen-
tative of at least two experiments with at least three mice per group. CCL2 broad array data are representative of three different experiments with at least 
three mice per group. Statistical analysis of CCL2 protein data was conducted using one-way ANOVA with a Tukey-Kramer post test. Neutralization ex-
periments were analyzed using a two-tailed unpaired   t   test comparing neutralized to nonneutralized WNV infected mice. *, P   <   0.05; ***, P   <   0.001. Bars: 
(B,  i)  200   μ M;  (B,  ii – iv)  50   μ M.   JEM VOL. 205, September 29, 2008 
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to delineate between resident (GFP       ) and immigrating (GFP  +  ) 
myeloid cells but also defi  nitively to distinguish between CD45  hi   
macrophages and CD45  lo/int   microglia (  29, 50, 53  ). Infected 
cFMS-EGFP chimeras displayed widespread leukocyte 
during infl  ammation is impossible. In the present study, BM 
from mice expressing EGFP on the cFMS promoter (CD115) 
were used as donors for chimeras. In conjunction with fl  ow 
cytometry staining for CD45 antigen, this allowed us not only 
    Figure 8.         CCL2 neutralization sequesters Gr1  hi   monocytes in the BM and blood of WNV-infected mice and prolongs the life of WNV-in-
fected animals.   Monocyte populations in the BM (BM-derived monocyte) and peripheral blood (peripheral blood monocyte) were investigated by fl  ow 
cytometry, based on the expression of EGFP-cFMS in conjunction with a cocktail of antibodies, including CD11b and CD45, using gating strategies indi-
cated in A, B, and C. CCL2 neutralization in WNV-infected EGFP-cFMS chimeras resulted in signifi  cant increases in Gr1  hi   (infl  ammatory monocytes) in 
both the BM and peripheral blood (D), as well as signifi  cantly prolonging the life of WNV-infected mice (E), compared with WNV-infected mice either 
treated with isotype control mAb or PBS during infection. Plaque assays (F) showed that CCL2 neutralization had no signifi  cant impact on the viral titer 
on day 7 p.i. Data shown are means   ±   SD and are representative of two different experiments with four mice per group. Neutralization experiments were 
analyzed using a two-tailed unpaired   t   test comparing neutralized to nonneutralized WNV-infected mice. *, P   <   0.05; ***, P   <   0.001. Kaplan-Meyer survival 
curves are representative of the results of two separate experiments with 10 mice per group in each. Data were analyzed using Prism Chi test (P   <   0.001).     2332 LY6C  HI   MONOCYTES BECOME MICROGLIA IN ENCEPHALITIS   | Getts et al. 
migration of monocyte-derived microglia, other studies sug-
gest that irradiation does not cause any pathological changes 
in the brain (  54, 55  ). Furthermore, the employment of head 
protection during irradiation not only protects the CNS from 
irradiation but also the large volume of blood within the 
brain, as well as the BM within the skull (  56, 57  ). Although 
it remains to be seen what role these elements play in traffi   ck-
ing of monocytes into the brain, the fi  ndings outlined here in 
nonirradiated mice indicate that infl  ammatory monocyte 
traffi   cking is an event triggered by viral encephalitis, a sce-
nario that has not previously been explored in this context. 
  Finally, similar increases in microglia are observed dur-
ing WNV infection in mice devoid of the fractalkine recep-
tor CX  3  CR  1   (unpublished data), which further implicates 
inflammatory monocytes as microglial precursors. How-
ever, as CX  3  CR  1   is expressed constitutively by resident 
microglia in the brain (  58  ), further investigation into the 
relationship between microglia and CX  3  CR  1    +  -circulating 
monocytes is needed. 
  The traffi   cking of infl  ammatory monocytes has been linked 
to the expression of CCR2 and production of CCL2 (  15, 16  ). 
WNV infection of the CNS resulted in signifi  cant amounts of 
CCL2 production. Neutralization of CCL2 resulted in a mas-
sive reduction of GFP  +   microglia in WNV-infected brains, 
clearly showing that the migration of infl  ammatory monocytes 
into the CNS is directed in part by the CCL2-CCR2 axis. 
However, the small number of GFP  +   cells that are still found 
to penetrate the WNV-infected brain after CCL2 neutraliza-
tion suggests that the other CCR2 ligands, CCL7 and CCL12, 
may also play a role in this model (  15, 16  ). 
  Investigation into the eff  ects of CCL2 neutralization dur-
ing WNV encephalitis on BM and circulating monocyte 
populations showed that CCL2 neutralization resulted in the 
retention of Ly6C  hi   monocytes both in the BM and circulat-
ing blood. This suggests, as shown previously in peripheral 
nonviral models, that CCL2 acts both at the level of BM 
recruitment at day 7 p.i. with numerous GFP  +   cells displaying 
microglial morphology. Microglial cell recruitment from the 
periphery was confirmed by the abundance of CD45  int   
CD11b  +  GFP  +   microglia isolated from day 7 p.i. cFMS-EGFP 
chimeras by fl  ow cytometry. Furthermore, we found that most 
of these microglia expressed Gr1 at similar levels to those 
seen on circulating infl  ammatory monocytes, whereas a large 
majority of resident (GFP       ) microglia did not. 
  It has been shown that irradiation of the CNS may alter 
patterns of monocyte traffi   cking into the brain in synthetic 
models of CNS inflammation (  10  ). Therefore, ability of 
Ly6C  hi   monocytes to traffi   c to the WNV-infected CNS in 
nonirradiated mice was confi  rmed using two diff  erent tracking 
techniques. First, we showed that adoptively transferred 
Ly6C  hi   BM-derived monocytes traffi   cked preferentially to the 
WNV-infected CNS, compared with Ly6C  lo   BM-derived 
monocytes. Although it may be argued that the use of BM-
derived monocytes rather than blood-derived monocytes may 
skew the interpretation of our results, it is important to note 
that the outcome of the experiment further supports the role 
of infl  ammatory monocytes as microglial precursors. This is 
because Ly6C  hi   infl  ammatory monocytes also act as precursors 
for circulating monocytes, in which case they down-regulate 
Ly6C as they circulate (  14, 49  ). 
  Furthermore, we stably labeled Ly6C  hi   infl  ammatory mon-
ocytes using a previously described method (  14  ). We found 
during WNV encephalitis that FITC bead  –  labeled mono-
cytes traffi   cked into the WNV-infected brain and developed 
a microglial phenotype, as determined by the expression of 
CD45, MHC-II, and CD86. Therefore, these data not only 
clearly show that infl  ammatory monocytes, rather than circu-
lating monocytes, act as microglial precursors during WNV 
encephalitis but that infl  ammatory monocyte migration into 
the CNS does not require radiation preconditioning or obvious 
BBB disruption (  10  ). Although our data confl  ict with previ-
ous reports showing that irradiation plays a critical role in the 
    Table I.        Antibodies used in this study 
Antibody Method Concentration Source Isotype Source
WNV-NS-1-biotin  +  IHC 1:100 R. Hall (University of Queensland, 
Brisbane, Australia)
Mouse IgG1 BioLegend
GS-lectin-biotin  +  /FITC IHC 1:50 Sigma-Aldrich N/A N/A
CD11b-APC/PE/APC-CY7/Alexa-700 FC 1:100 BD Biosciences    /
BioLegend
Rat IgG  2b BD  Biosciences/ 
BioLegend
CD45-PerCP FC 1:100 BD Biosciences Rat IgG  2b BD  Biosciences
Ly6C-FITC/ Biotin FC 1:100 BD Biosciences Rat IgM BD Biosciences
Ly6G-PE FC 1:100 BD Biosciences BD Biosciences
GR1-biotin/APC-Cy7/ Pacifi  c blue FC/IHC 1:100 BD Biosciences    /
BioLegend
Rat IgG  2b BD  Biosciences/ 
BioLegend
CD11c-biotin  +  /PE-Cy7 FC 1:150 BD Biosciences    /
Biolegend
Hamster IgG BD Biosciences/ 
BioLegend
CCL2-LEAF Neut 100   μ  g per mouse BioLegend Hamster IgG-LEAF BioLegend
CD115-PE FC 1:50 eBioscience Rat IgG  2A BioLegend
FC, fl  ow cytometry; Neut, neutralization; biotin  + ,  biotinylated.JEM VOL. 205, September 29, 2008 
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(that are also likely to be derived from infl  ammatory mono-
cytes) or CCR2-expressing T cells in the pathogenesis of 
WNV encephalitis. However, work conducted by several in-
dependent groups suggests that macrophages and T cells, re-
cruited in a CCR5-dependent manner, are important in viral 
clearance and do not drive immunopathology (  19  ). 
  In conclusion, this is the fi  rst study to show that microglia 
are derived from infl  ammatory monocytes using CCL2 dur-
ing a fatal model of fl  aviviral encephalitis. These exogenously 
derived microglia appear to bolster the endogenous microg-
lial population. This CCL2-dependent migration appears to 
play a role in the pathogenesis of disease, as CCL2 neutraliza-
tion prolonged the life of infected mice. The role of infi  ltrat-
ing infl  ammatory monocytes in mediating immunopathology 
during WNV encephalitis requires further investigation; 
however, their peripheral location before migration to the 
brain suggests that modulating these cells may serve as a novel 
therapy, not only during encephalitic disease but during other 
CNS disorders also. 
  MATERIALS AND METHODS 
  Virus propagation.     As previously described (  62  ), WNV (Sarafend) was 
derived from the brains of neonatal mice, which were used to infect confl  u-
ent vero cell monolayers, at a multiplicity of infection of 5 PFU per cell. In-
fected cells were incubated for 40 h, after which they were frozen. Flasks 
were then thawed and the virus-rich supernatant clarifi  ed by centrifugation, 
after which aliquots were stored at     70  °  C until use. 
  Mice and infection.     8  –  16-wk-old female C57BL/6 (CD45.2) and con-
genic B6.SJL-Ptprc  a  Pep3  b  /BoyJ (CD45.1), C57BL/6-7.2fms-EGFP trans-
genic (CD45.2) mice were obtained from the Blackburn animal house 
(University of Sydney, Sydney, Australia) or the Animal Resources Center 
(Western Australia). All procedures were performed with permission of the 
University of Sydney Animal Ethics Committee. All animals were housed 
under class II biohazard conditions in hepa fi  lter-top cages. Food and water 
was provided ad libitum. 
  Intranasal infection was conducted as previously described with WNV 
6   ×   10  4   PFU in sterile PBS (Invitrogen). Sham infections were conducted by 
inoculating with sterile PBS only (  62, 64  ). 
  Mice were killed using cardiac perfusion of anaesthetised mice with 
40 ml of ice-cold PBS followed by perfusion with 20 ml of 4% PFA (Sigma-
Aldrich) in PBS for histology or 50 ml PBS only for fl  ow cytometry. 
  Plaque assay to determine viral titer.     A virus plaque assay with virally 
susceptible BHK cells (donated by G. Karupiah, John Curtin Medical 
School, Canberra, Australia) was used. Tissue samples were dissected from 
animals and were immediately frozen in liquid nitrogen. 10% (wt/vol) tis-
sues homogenates were prepared in Roswell Park Memorial Institute 1640 
media (RPMI; CSL Biosciences) immediately before virus titration. In 
brief, thawed tissue samples were weighed in 2-ml screw cap tubes 
(SARSTEDT) before being disassociated with a power homogenizer (Tis-
sue Tearor; BioSpec). The homogenates were then clarifi  ed by centrifuga-
tion at 1,500 rpm for 5 min at 4  °  C. The homogenate supernatant was used 
to infect BHK cells. Blood was collected from mice via the brachial artery. 
The samples were allowed to sit at 4  °  C for 8 h to coagulate before serum 
and plasma were separated by a high-speed 12,000 rpm centrifugation at 
4  °  C. Supernatant serum was collected from centrifuged samples and stored 
in aliquots at     70  °  C. 
  BHK cells were seeded into 6-well plates at 1   ×   10  6   cells per well in 
2 ml RPMI overnight at 37  °  C in a 5% CO  2   incubator. Media was removed 
from the cells and replaced with 150   μ  l of virus samples at various dilutions. 
egress and also at the BBB interface (  15, 16  ). It appears that 
the single-pulse antibody-mediated systemic reduction of the 
very high levels of CCL2, in the face of the high throughput 
of monocytes from the BM to the brain at this time point, 
may reduce immigration of monocytes into the brain before 
the eff  ect of BM egress is apparent, causing an increase in 
blood monocyte numbers, which is in contrast to the eff  ect 
of genetic absence of CCL2 (  15  ). 
  The infi  ltration of CD11b  +  CD45  +   myeloid cells has been 
implicated in the pathogenesis of WNV disease (  21, 22  ). This 
has been argued to be because of infected infi  ltrating cells act-
ing in a Trojan horse manner, enabling WNV entry from the 
periphery into the brain in association with breakdown of the 
BBB (  21, 22, 59, 60  ). However, more recently it has been 
shown that WNV entry into the CNS is mediated via axonal 
transport (  61  ), and integrity of the BBB does not necessarily 
predict disease outcomes ( 45  ). In our model of intranasal WNV 
infection, infectious virus can be isolated from the brain several 
days (day 3 p.i) before monocyte infi  ltration occurs (  61, 62  ), 
which is consistent with the expression of CCL2 by infected 
neurons attracting monocytes into the brain from the blood-
stream. Therefore, the observation that CCL2 neutralization 
prolongs the survival of infected mice, although apparently 
having no eff  ect on viral titer, suggests that infl  ammatory 
monocyte-derived microglia are likely to play a pathogenic 
role in WNV encephalitis, which is not simply explained by 
their possible role in viral dissemination (  61, 62  ). 
  It could be argued that the intranasal model of WNV in-
fection is irrelevant in not mimicking natural infection. How-
ever, in all the published models of peripheral inoculation, the 
signifi  cant peripheral immune activation makes it impossible 
to separate the contribution of the systemic immune response 
to brain pathology that leads to death from the direct contri-
bution of systemic immune response to death, independently 
of brain involvement. This is an important distinction that 
needs to inform interventional approaches to disease. The ne-
cessity of distinguishing experimentally between pathological 
events in the periphery and those in the brain has directed our 
development of this model. Furthermore, this distinction is 
likely to explain why macrophage deletion in peripheral in-
oculation results in enhanced mortality, whereas in our model 
it increases survival (  63  ). 
  The exact role of microglia in immune-mediated pathol-
ogy during WNV infection requires further investigation. 
Although it is likely that microglia secrete numerous proin-
fl  ammatory cytokines, because we have shown the impor-
tance of glutamate excitotoxicity during WNV infection, we 
suggest that pathogenic functions of microglia may reside in 
diff  erential roles of immigrant and resident microglia in regu-
lating neuronal function. Although much work is required to 
prove this, when considering the exclusively neuronal local-
ization of WNV (  62  ) and the importance of microglia in reg-
ulating the neurological environment, it is not unreasonable 
to speculate that infl  ammatory monocyte-derived microglia 
may play a pathogenic role in this phenomenon. Our data can-
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positive cells were enumerated throughout the entire brain parenchyma on 
eight brains, two sections per brain, at days 6 and 7 p.i. from whole sagittal 
brain sections on double-blinded glass slides. 
  Microscope and image acquisition.     Images were acquired on a micro-
scope (BX-51; Olympus), using a camera (DP-70; Olympus) and DP man-
ager 2.2.1 software (Olympus). 
  In-situ hybridization for CCL2.     Paraffi   n-embedded sections were incu-
bated with P  33  -labeled cRNA probes transcribed from linearized plasmid 
constructs containing the CCL2 cDNA and processed for in situ hybridiza-
tion histochemistry as described previously (  61  ). 
  CNS leukocyte isolation.     As previously described (  69  ), leukocytes were 
obtained from the brains of infected mice by digesting brains in PBS with 
DNase (0.005 g/ml; Sigma-Aldrich) and collagenase IV (0.05 g/ml; Sigma-
Aldrich) for 60 min at 37  °  C. Digestion was stopped with 10% FCS. The 
subsequent homogenate was passed through a nylon cell strainer with a 70-  μ  m 
mesh size (Becton Dickinson). The pellet, obtained after 10-min centrifuga-
tion at 340   g  , was resuspended in 30% percoll (GE Healthcare) and layered 
over 80% Percoll. Leukocytes were collected from the 30/80% interface af-
ter centrifugation at 1,140   g   for 25 min at room temperature. 
  BM-derived monocyte and peripheral blood monocyte isolation.   
  For fl  ow cytometry analysis, the right femur was dissecting out and BM cells 
fl  ushed out using PBS-loaded syringes. In the case of BM precursor isolation, 
femurs and tibias from at least four mice were used. The cellular suspension 
achieved after fl  ushing was fi  ltered through a 70-  μ  m cell strainer and centri-
fuged for 5 min at 340   g  . The red cells in the resulting pellet were lysed in 
NH  4  Cl        red cell lysis buff  er before being centrifuged for 5 min at 340   g  . In 
the case of peripheral blood, blood was collected via cardiac puncture im-
mediately into citrate buff  er (mmol; Sigma-Alrich). The resulting suspension 
was layered over 30% percoll and centrifuged at 1,140   g   for 20 min at room 
temperature with the brake off  . The interface was collected and the cells 
were washed once in PBS and centrifuged at 340   g  . 
  Flow cytometry.     Cells collected as described in the previous section from 
brain, blood, or BM were then washed in PBS and blocked with anti-
CD16/CD32 (BioLegend) antibody. Viable cells were counted using trypan 
blue exclusion, which routinely showed   >  95% cell viability. The antibodies 
utilized for fl  ow cytometry are outlined in   Table I  .   
  Cell surface molecule expression was measured and cell sorts were per-
formed on a FACS ARIA (Becton Dickinson), equipped with an Argon ion 
and HeNe laser. Viable populations were gated by forward and side scatter 
and identifi  ed fl  uorescent populations determined by forward-gating there-
after. Sorting was performed using specifi  c fl  uorescent and scatter parameters 
identifying the population of interest. Sorting stringencies was set to purity 
to achieve   >  98% purity for BM populations. 
  Acquired FACS data fi  les were analyzed using the fl  ow cytometry pro-
gram Flow Jo (Tree Star, Inc.). Quantifi  cation of cell populations of interest 
were calculated based on fl  ow cytometry percentages at analysis and absolute 
cell counts from each organ. 
  Adoptive transfer.     We sorted both Ly6C  hi  /cFMS-EGFP  +  /CD11b  +   and 
Ly6C  lo  /Cfms-EGFP  +  /CD11b  +   populations from day 6 intranasally WNV-
infected mice. Ly6C  hi   BM was labeled with 10 mM cell tracker orange 
(CMTMR [5-(and -6)-(((4-chloromethyl) benzoyl) amino) tetramethyl-
rhodamine)-mixed isomers; Invitrogen). In brief, sorted cells were centri-
fuged and raised in 1 ml PBS containing 10   μ  M CMTMR. Cells were 
stained for 10 min before the reaction was stopped with 10% FCS. Cells 
were washed in 50 ml PBS at least three times. Labeled CMTMR Ly6C  hi   
BM cells were then mixed 1:1 with Ly6C  lo   cells, which, except for the addi-
tion of CMTMR, had been treated similarly to Ly6C  hi   populations. A total 
of 2   ×   10  6   BM cells were i.v. injected into either day 6.5 WNV-infected or 
mock-infected Ly5.1-C57BL/6 congenic mice. 12 h later, brains were 
For tissue samples, fi  vefold dilutions were prepared, whereas serum samples 
were titrated twofold only. One well per plate was reserved as a negative 
control. Plates were incubated and rocked every 15 min for 1 h at 37  °  C. The 
inoculum was removed by aspiration and the wells overlaid with 3 ml of 
1.5% (wt/vol) low-gelling Agarose II (Amresco) in 2  ×   MEM (Invitrogen). 
The agarose plugs were allowed to solidify before plates were incubated for 
a further 3 d at 37  °  C. After this period, wells were fi  xed with 3 ml of 10% 
formalin (Sigma-Aldrich) for 2 h before agarose plug removal. Fixation was 
necessary to kill free virus and to harden the agarose plug to facilitate re-
moval. A 3% crystal violet (Hopkins and Williams) dye solution in 20% 
methanol (Fronine) was used to stain fi  xed cells. Excess crystal violet was 
washed off   with PBS. Plates were dried overnight before plaques were 
counted using a colony counter (IUL, S. A.). The fi  nal PFU per gram (tis-
sue) or milliliter (serum) was determined by factoring the number of plaques, 
the inoculum volume, and the dilution. 
  Generation of chimeric mice.     6  –  8-wk-old B6.SJL-PtprcaPep3b/BoyJ 
(CD45.1) mice were irradiated with one dose of 950 rads. 12 h later, mice 
were reconstituted with 10  7  donor BM cells from C57BL/6-7.2fms-EGFP 
BM. Mice were given sulfamethoxazole (Sigma-Aldrich) and trimethoprim 
(Sigma-Aldrich) in drinking water for 10 d after irradiation. 6  –  12 wk after 
irradiation, mice were infected with WNV as described in Mice and infec-
tion. Chimerism was checked using fl  ow cytometry and was invariably found 
to be 96  –  99% of donor origin (Fig. S5). 
  Clodronate liposome depletion and FITC bead labeling of circulat-
ing monocytes.     As previously shown, clodronate-encapsulated liposomes 
is an effi   cient method for depleting circulating macrophages (  65  –  67  ). Clo-
dronate was a gift of Roche. It was encapsulated in liposomes as described 
previously, and PBS-encapsulated liposomes were used as controls (  65  –  67  ). 
Macrophages were depleted with multiple injections of clodronate-encapsu-
lated liposomes on days 1, 3, and 5 after WNV infection. In the case of lipo-
some tracking experiments, liposomes containing PBS were labeled with Dil 
(Invitrogen) and injected intravenously on day 7 p.i. 
  To label circulating monocytes, the previously described protocol (  14, 
50  ) was modifi  ed. C-L liposomes were injected i.v. on day 5.5 p.i. 12 h later, 
a second i.v. injection of FITC Flouresbrite polystyrene beads (Polyscience) 
diluted 1:25 in PBS was given. Control nonclodronate liposome treatment 
groups injected with PBS only or beads only were also used. 
  Immunohistology.     As previously described (  62  ), perfused brains and spleens 
were processed into paraffi   n blocks for sectioning. Sagittal 8-  μ  m sections 
were cut for both routine H  &  E staining and IHC. 
  Antigen retrieval for WNV labeling was conducted as previously de-
scribed (  62  ). Antigen retrieval for lectin labeling was conducted using citrate 
buff  er in a microwave oven set on 600 W for 8 min and allowed to cool for 
25 min. Staining protocols for WNV antigen and lectin were identical and 
as previously described (  62  ). 
  Fluorescence IHC was performed for the Gr1 complex with biotinyl-
ated Gr1 antibody (BioLegend) on cFMS-EGFP chimeras. In this case, brain 
tissue was fi  xed in 4% PFA at 4  °  C for 4 h and then immersed in 30% sucrose 
overnight, before being frozen in optimum cutting temperature compound 
(OCT; Tissue-Tek). 8-  μ  m tissue sections were cut on a cryostat microtome 
and air dried. Fluorescence IHC was performed as previously described (  62  ) 
with the addition of a tyramide-based amplifi  cation system (TSA kit; Perkin-
Elmer) used according to the manufacturer  ’  s instructions. 
  The presence of D-L liposomes was investigated on frozen 8-  μ  m brain 
and spleen sections. In addition, slides were incubated with FITC-conju-
gated lectin (Sigma-Aldrich) for 60 min before counter stain with DAPI an-
tifade (Vector Laboratories). 
  BrdU incorporation.     To detect proliferating cells, mice received 75 mg/
kg BrdU (Becton Dickinson) i.v. 3 h before sacrifi  ce on days 6 and 7 p.i. 
Proliferating cells were detected in situ by IHC using an anti-BrdU antibody 
on paraffi   n-embedded tissues (Skybio), as previously described (  68  ). BrdU-JEM VOL. 205, September 29, 2008 
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harvested as described in Mice and infection and CNS leukocyte isolation, 
and the presence of donor cells was investigated using fl  ow cytometry, both 
using cFMS-EGFP and CMTMR  –  cell tracker orange. 
  CCL2 ELISA and neutralization.     As previously described (  62  ), cytokine 
bead arrays (Becton Dickinson) were used to measure CCL2 protein con-
centration in both serum and brain homogenates according to the manufac-
turer  ’  s instructions. CCL2 neutralization was conducted by giving 100   μ  g 
CCL2 (clone: 2H5; BioLegend) or isotype control (Hamster IgG; BioLeg-
end) antibody injections i.p. late on days 5 and 6 consecutively. Late day 7 
mice were killed and perfused, and PBMS, BMMC, and infi  ltrating CNS 
leukocytes were prepared as described as described in Mice and infection and 
CNS leukocyte isolation. 
  Statistics.     Graphs were made and computerized statistical analysis was per-
formed in Prism and InStat, respectively (both programs from GraphPad 
software, Inc.). Depending on the data, an unpaired, two-tailed Student  ’  s 
  t   test or one way ANOVA with a Tukey-Kramer post test was performed, 
with P   <   0.05 considered to be signifi  cant. 
  Online supplemental material.     Fig. S1 shows Lectin and NS-1 IHC on 
day 7 p.i. throughout the brain. Fig. S2 shows control labeling for BrdU 
by fl  ow cytometry in microglia and T cells in the brain and CD11b  +   cells 
in BM in infected mice and in vitro  –  activated splenocytes. Fig. S3 shows 
Evans blue staining of the brain in WNV infection. Fig. S4 shows depletion 
of Ly6C  hi   and Ly6C  lo   monocytes in vivo by clodronate liposomes. Fig. S5 
shows the purity of the cFMS-EGFP chimeras. Fig. S6 shows that acute 
CCL2 neutralization of mock-infected mice has no eff  ect on monocyte 
populations. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20080421/DC1. 
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